Precigen, Inc. (PGEN) financial statements (2022 and earlier)

Company profile

Business Address 20374 SENECA MEADOWS PARKWAY
GERMANTOWN, MD 20876
State of Incorp. VA
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments115114115106100113133
Cash and cash equivalents43423627522847
Short-term investments72737978488586
Receivables21212721201924
Inventory, net of allowances, customer advances and progress billings13101111111013
Inventory13101111111013
Disposal group, including discontinued operation  0010  
Other undisclosed current assets7836794
Total current assets:157153157144149151173
Noncurrent Assets
Operating lease, right-of-use asset111212991921
Property, plant and equipment34333334354547
Long-term investments and receivables496785104 01
Long-term investments496785104 01
Intangible assets, net (including goodwill)108111114115120119119
Goodwill54545454545454
Intangible assets, net (excluding goodwill)54576061656565
Other noncurrent assets1111211
Total noncurrent assets:203224246263166185189
TOTAL ASSETS:360377403407315336362
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28232318222121
Accounts payable5454544
Accrued liabilities12111071099
Employee-related liabilities11886888
Deferred revenue4434347
Debt00000032
Due to related parties0000000
Disposal group, including discontinued operation  0014  
Other undisclosed current liabilities2223355
Total current liabilities:35292925423164
Noncurrent Liabilities
Long-term debt and lease obligation192191189181179214212
Long-term debt, excluding current maturities183180177174172194191
Operating lease, liability101112782021
Liabilities, other than long-term debt26262626263336
Deferred revenue23232323233033
Deferred income tax liabilities3333333
Other liabilities0000000
Total noncurrent liabilities:218217215207205247248
Total liabilities:253246243232247278312
Stockholders' equity
Stockholders' equity attributable to parent107131159175675950
Additional paid in capital2,0232,0202,0172,0141,8871,8391,802
Accumulated other comprehensive income (loss)023241(1)
Accumulated deficit(1,916)(1,891)(1,861)(1,841)(1,823)(1,782)(1,752)
Total stockholders' equity:107131159175675950
TOTAL LIABILITIES AND EQUITY:360377403407315336362

Income statement (P&L) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues24223425192430
Gross profit:24223425192430
Operating expenses (4)(5)  (7)(10)
Operating income:24172825191721
Income from continuing operations before equity method investments, income taxes:24172825191721
Loss from equity method investments   (0)(0)  
Other undisclosed loss from continuing operations before income taxes(49)(47)(48)(46)(20)(47)(64)
Loss from continuing operations before income taxes:(25)(30)(20)(22)(1)(30)(43)
Income tax expense (benefit)(0)  0(0)  
Loss from continuing operations:(25)(30)(20)(22)(1)(30)(43)
Income (loss) from discontinued operations 005(41)  
Loss before gain (loss) on sale of properties:(25)(30)(20)(17)(42)(30)(43)
Other undisclosed net income (loss)   (0)000
Net loss:(25)(30)(20)(17)(42)(30)(43)
Other undisclosed net income attributable to parent000    
Net loss available to common stockholders, diluted:(25)(30)(20)(17)(42)(30)(43)

Comprehensive Income ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(25)(30)(20)(17)(42)(30)(43)
Other comprehensive income (loss) (1)1(2)   
Other undisclosed comprehensive income (loss)(1)   321
Comprehensive loss:(26)(31)(19)(20)(39)(27)(43)
Other undisclosed comprehensive income, net of tax, attributable to parent000    
Comprehensive loss, net of tax, attributable to parent:(26)(31)(19)(20)(39)(27)(43)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: